Equillium, Inc. Form 8-K Summary
Business Context and Reporting Period
Equillium, Inc. filed a Current Report on Form 8-K dated April 5, 2023, with the filing signed on April 6, 2023. The filing reports a Nasdaq continued-listing deficiency under Item 3.01. It does not provide financial statements or results for a reporting period.
Financial Metrics and Liquidity
The filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, cash balance, or other operating or financial metrics.
Material Change Versus Prior Period
On April 5, 2023, Nasdaq notified the Company that its common stock had closed below the minimum bid price of $1.00 per share for 30 consecutive business days, resulting in noncompliance with Nasdaq Listing Rule 5450(a)(1).
- The notice had no immediate effect on the listing or trading of the common stock on The Nasdaq Global Market.
- The Company was granted 180 days, through October 2, 2023, to regain compliance.
- Compliance requires a minimum bid price of at least $1.00 per share for at least 10 consecutive business days during the compliance period.
Outlook, Risks, and Unusual Items
If the Company did not regain compliance by October 2, 2023, it could have been eligible for an additional 180-calendar-day compliance period by transferring to The Nasdaq Capital Market, subject to satisfying the applicable market value and other initial listing requirements and providing written notice of its intent to cure the deficiency.
Failure to regain compliance during the applicable period could result in delisting. The Company stated that it intended to monitor its share price and consider available actions, including a reverse stock split, to regain compliance. The filing does not state whether a reverse stock split was approved, authorized, or implemented.
Key Facts for Investor Verification
- Whether the Company regained compliance by October 2, 2023, or obtained an additional compliance period.
- Whether the Company transferred its listing to The Nasdaq Capital Market.
- Whether the Company implemented or proposed a reverse stock split or another remedial action.
- Any subsequent Nasdaq delisting notice, appeal, or change in trading venue.
- The Company’s financial condition and liquidity, which are not addressed in this filing.